FibroBiologics Inc. Commo... (FBLG)
NASDAQ: FBLG
· Real-Time Price · USD
0.57
-0.02 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.57
-1.21%
After-hours: Aug 15, 2025, 05:55 PM EDT
FibroBiologics Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | n/a | n/a | 554K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 206K | n/a | 153K | n/a | 140K | 137K | 130K | 112K | n/a | 96K | n/a | n/a | n/a | n/a |
Gross Profit | -206K | n/a | 277K | n/a | -140K | -137K | -130K | -112K | n/a | -96K | n/a | n/a | n/a | n/a |
Operating Income | -4.49M | -4.53M | -3.71M | -3.35M | -3.22M | -3.45M | -2.48M | -2.05M | -2.09M | -2.27M | -1.3M | -1.34M | -911K | -911K |
Interest Income | 50K | 99K | 63K | 79K | 70K | 39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.56M | -1.02M | -1.02M |
Net Income | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.56M | -1.02M | -1.02M |
Selling & General & Admin | 2.24M | 2.75M | 2.36M | 2.14M | 2.25M | 2.39M | 1.61M | 1.38M | 1.55M | 1.69M | 959K | 993K | 684K | 684K |
Research & Development | 2.04M | 1.78M | 1.31M | 1.21M | 938K | 925K | 742K | 561K | 543K | 477K | 345K | 348K | 227K | 227K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15K | n/a | n/a | n/a | n/a |
Operating Expenses | 4.28M | 4.53M | 3.56M | 3.35M | 3.22M | 3.31M | 2.35M | 1.94M | 2.09M | 2.17M | 1.3M | 1.34M | 911K | 911K |
Interest Expense | n/a | n/a | 6K | 5K | 5K | 4K | 1K | n/a | 11K | 135K | 220K | 221K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -102K | -99K | -99K | n/a | -95K | 392K | n/a | n/a | n/a |
Cost & Expenses | 4.49M | 4.53M | 3.71M | 3.35M | 3.22M | 3.45M | 2.48M | 2.05M | 2.09M | 2.27M | 1.3M | 1.34M | 911K | 911K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -46K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 38.64M | 36.67M | 32.88M | 33.52M | 32.72M | 32.72M | 28.23M | 32.49M | 32.48M | 32.72M | 28.23M | 32.49M | 28.23M | 28.23M |
Shares Outstanding (Diluted) | 38.64M | 36.67M | 32.88M | 33.52M | 32.72M | 32.72M | 28.23M | 32.49M | 32.48M | 32.72M | 28.23M | 32.49M | 28.23M | 28.23M |
EPS (Basic) | -0.12 | -0.14 | -0.09 | -0.01 | 0.03 | -0.26 | -0.34 | -0.07 | -0.07 | -0.07 | -0.05 | -0.05 | -0.04 | -0.04 |
EPS (Diluted) | -0.12 | -0.14 | -0.09 | -0.01 | 0.03 | -0.26 | -0.34 | -0.07 | -0.07 | -0.07 | -0.05 | -0.05 | -0.04 | -0.04 |
EBITDA | -4.45M | -4.8M | -2.94M | -352K | 1.04M | -8.32M | -9.59M | -2.08M | -2.05M | -2.18M | -1.21M | -1.34M | n/a | n/a |
EBIT | -4.66M | -4.97M | -3.09M | -495K | 903K | -8.46M | -9.72M | -2.19M | -2.15M | -2.28M | -1.3M | -1.34M | -911K | -911K |
Depreciation & Amortization | 206K | 161K | 153K | 143K | 140K | 137K | 130K | 112K | 99K | 96K | 1.3M | n/a | 911K | 911K |